Immunovia Dx Laboratories

Immunovia is a diagnostic company focused on developing and commercializing highly accurate blood tests for the early detection of cancer. The company's proprietary technology platform, IMMURay, utilizes an antibody-based microarray to profile a patient's immune system response to disease through serum protein biomarkers. Their lead product, IMMURay PanCan-d, was the first blood test dedicated to the early detection of pancreatic cancer in high-risk individuals. While the company recently pivoted to develop a next-generation protein-based test to improve accuracy and cost-efficiency, it remains a leader in the field of multi-marker diagnostics for oncology.